Antimicrobial Peptides PL-18(Jiangsu Pulai Pharmaceutical Biotechnology)

N/A

Report date: 2023/12/08 16:04:15
NME

Base Information

Drug NameAntimicrobial Peptides PL-18(Jiangsu Pulai Pharmaceutical Biotechnology)
Drug Alias Name抗菌肽PL-18PL-18 polypeptide suppositoryPL-18 suppositoryPL-18
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVaginitisCandidiasis, VulvovaginalVaginosis, Bacterial +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPle Pharmacy (Jiangsu) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesProtelight Pharmaceuticals Australia Pty LtdPle Pharmacy (Jiangsu) Co Ltd
Inactive CompaniesN/A
Active IndicationsVaginitisCandidiasis, VulvovaginalVaginosis, Bacterial +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A